Ardelyx (ARDX) EBT (2013 - 2026)
Ardelyx's (ARDX) quarterly EBT came in at -$37.6 million in Q1 2026, up 6.67% YoY from -$35.2 million in Q1 2025, and down 9299.25% on a QoQ basis from -$400000.0 in Q4 2025.
Ardelyx (ARDX) EBT (2013 - 2026) Analysis & Trends
Ardelyx (ARDX) has 14 years of EBT data on file, last reported at -$37.6 million in Q1 2026.
- Quarterly EBT rose 6.67% year-over-year to -$37.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$57.9 million (down 9.83% YoY) and the FY2025 annual result came in at -$60.6 million, down 55.98% from the prior year.
- EBT fell to -$37.6 million in Q1 2026, from -$400000.0 in the prior quarter.
- In the past five years, EBT ranged from a high of $10.7 million in Q4 2022 to a low of -$40.3 million in Q1 2025.
- A 5-year average of -$15.9 million and a median of -$19.1 million in 2025 frame the typical range for EBT.
- The widest YoY moves for EBT: up 129.83% in 2023, down 366.19% in 2023.
- Tracing ARDX's EBT over 5 years: stood at $10.7 million in 2022, then tumbled by 366.19% to -$28.5 million in 2023, then jumped by 116.44% to $4.7 million in 2024, then tumbled by 108.55% to -$400000.0 in 2025, then sank by 9299.25% to -$37.6 million in 2026.
- The last three EBT figures came in at -$37.6 million (Q1 2026), -$400000.0 (Q4 2025), and -$867000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn | -16.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.61 Mn |
| Mar 31, 2026 | -37.60 Mn |
| Dec 31, 2025 | -400,000.00 |
| Sep 30, 2025 | -867,000.00 |
| Jun 30, 2025 | -19.08 Mn |
| Mar 31, 2025 | -40.29 Mn |
| Dec 31, 2024 | 4.68 Mn |
| Sep 30, 2024 | -766,000.00 |
| Jun 30, 2024 | -16.39 Mn |
| Mar 31, 2024 | -26.40 Mn |
| Dec 31, 2023 | -28.47 Mn |
| Sep 30, 2023 | 6.83 Mn |
| Jun 30, 2023 | -17.12 Mn |
| Mar 31, 2023 | -26.76 Mn |
| Dec 31, 2022 | 10.70 Mn |
| Sep 30, 2022 | -22.89 Mn |
| Jun 30, 2022 | -26.93 Mn |
| Mar 31, 2022 | -28.07 Mn |
| Dec 31, 2021 | -36.23 Mn |
| Sep 30, 2021 | -43.59 Mn |